To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
USA118th CongressHR-1393| House
| Updated: 3/17/2023
Madeleine Dean
Democratic Representative
Pennsylvania
Cosponsors (18)
Robert Garcia (Democratic)Sheila Jackson Lee (Democratic)Zachary Nunn (Republican)Mariannette Miller-Meeks (Republican)Ted Lieu (Democratic)Ro Khanna (Democratic)Morgan Luttrell (Republican)Jasmine Crockett (Democratic)Don Bacon (Republican)James R. Baird (Republican)Nancy Mace (Republican)Bonnie Watson Coleman (Democratic)Brandon Williams (Republican)Derrick Van Orden (Republican)Colin Z. Allred (Democratic)Earl Blumenauer (Democratic)Mike Thompson (Democratic)Bill Johnson (Republican)
Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Crime and Law Enforcement
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
USA118th CongressHR-1393| House
| Updated: 3/17/2023
This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Madeleine Dean
Democratic Representative
Pennsylvania
Cosponsors (18)
Robert Garcia (Democratic)Sheila Jackson Lee (Democratic)Zachary Nunn (Republican)Mariannette Miller-Meeks (Republican)Ted Lieu (Democratic)Ro Khanna (Democratic)Morgan Luttrell (Republican)Jasmine Crockett (Democratic)Don Bacon (Republican)James R. Baird (Republican)Nancy Mace (Republican)Bonnie Watson Coleman (Democratic)Brandon Williams (Republican)Derrick Van Orden (Republican)Colin Z. Allred (Democratic)Earl Blumenauer (Democratic)Mike Thompson (Democratic)Bill Johnson (Republican)
Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
Crime and Law Enforcement
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted